Dr. Mounir Y. Abdelshahid, MD

Dr. Abdelshahid practices at Clark Medical Service in Bloomfield, New Jersey.

Dr. Abdelshahid's NPI, 1780872838, was assigned on October 12, 2007. Dr. Abdelshahid holds New Jersey license 25MA08321900.

Dr. Abdelshahid's primary practice is Clark Medical Service, at 135 Bloomfield Ave, Bloomfield, NJ 07003 in Essex County. The practice phone is (862) 213-0033.

Dr. Abdelshahid's primary practice is Clark Medical Service in Bloomfield, New Jersey. Dr. Abdelshahid is also affiliated with JFK University Medical Center. The medical group on file is Dr. Mounir Y. Abdelshahid, MD. Dmand AI also links Dr. Abdelshahid to 3 more hospitals, 5 skilled nursing facilities, 4 home health agencies, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdelshahid practices, 15 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Abdelshahid's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Abdelshahid is licensed in New Jersey.

CMS data shows 17,490 Medicare services from Dr. Abdelshahid across 19 procedure codes in 2024, for 502 Medicare patients. Medicare paid $454,454 for them.

CMS counts 502 Medicare patients who saw Dr. Abdelshahid in 2024. The largest group is 65 to 74, with 178 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 51% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdelshahid's median patient age at 67, with 55% women.

In 2024, Dr. Abdelshahid wrote 21,766 Medicare Part D claims for 732 patients. 81% of them were for generic drugs. CMS names the drug for 20,731 of them, across 289 drugs with 11 or more claims each, at $2,852,896 in total drug cost. In 2023, CMS named 14,531 claims across 240 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Abdelshahid for performance year 2024, reported as part of a group. Dr. Abdelshahid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abdelshahid as offering telehealth.

CMS Open Payments shows 499 general payments to Dr. Abdelshahid from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,147.